Clinical trial Recruiting at 3 sites Observational Ages 18 to 85 Women only

Minimally invasive versus open radical hysterectomy for early-stage cervical cancer

Official title: Minimally Invasive Surgery Versus Open Radical Hysterectomy in Presumably Early Stage Cervical Cancer: a Retrospective Multicenter Non-inferiority Study Comparing Overall and Progression-free Survival.

Run by Medical University of Silesia · NCT07120529 · Data updated 2026-11-12

This project tests whether laparoscopic (minimally invasive) radical hysterectomy works as well as open abdominal radical hysterectomy for adult women with early-stage cervical cancer who have negative sentinel lymph nodes.

More Cervical Cancer trials

Quick facts

Study typeObservational
Ages18 Years to 85 Years
SexWomen only
Enrollment300 (estimated)
SponsorMedical University of Silesia
Academic / other
Locations5 sites (Bialystok and 4 other locations)
StatusRecruiting
StartedSeptember 15, 2025
Main results expectedSeptember 1, 2030
Study endsDecember 1, 2030
Registry record updatedAugust 13, 2025
Trial IDNCT07120529 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adult, legally competent women with early-stage cervical cancer (FIGO IB1–IIA1, excluding IB3) who had a negative sentinel lymph node biopsy and underwent type B or C radical hysterectomy without a uterine manipulator and with a protective vaginal cuff closure.

Probably not a fit

Patients with more advanced disease (FIGO >IIA1 or IB3), positive sentinel nodes, poor performance status (ECOG >2), or those unwilling to undergo required imaging and gynecologic follow-up are unlikely to benefit from the comparisons made here.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a retrospective multicenter study with prospective follow-up comparing long-term survival and perioperative outcomes after radical laparoscopic versus open abdominal hysterectomy performed after the LACC trial. Eligible cases are adult women with FIGO 2018 stages IB1–IIA1 (excluding IB3) and negative sentinel lymph nodes confirmed by ultrastaging. The cohort is restricted to surgeries without a uterine manipulator and with a protective vaginal cuff closure maneuver to limit tumor spill. Primary endpoints are overall survival and progression-free survival, with secondary endpoints including perioperative morbidity and recurrence patterns.

Why it matters

Potential benefit: If successful, the findings could allow eligible patients to receive minimally invasive hysterectomy with confidence that long-term survival and recurrence risk are similar to open surgery.

How similar studies have gone: A large randomized trial (LACC) reported worse outcomes with minimally invasive radical hysterectomy, while later retrospective series that used protective maneuvers have suggested comparable outcomes, so the approach has mixed and not yet definitive evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Women undergoing radical hysterectomy type B or C according to the Querleu-Morrow classification for early-stage cervical cancer (FIGO stages IB1-IIA1, excluding FIGO IB3 between November 2018 and August 2025 Not using manipulator during surgery Vaginal cuff protective maneuver during surgery Conization before surgery (optional) SNB as a first stage of treatment (optional)

Exclusion Criteria:

Women undergoing surgery for advanced stage cervical cancer (FIGO \>IIA1) or FIGO IB3 Metastasis detected in sentinel node biopsy (confirmed in ultrastaging) ECOG\>2 Not willing to participate in the study Not willing to undergo CT-scans or gynecological examinations

Where it's running

  • Department of Gynaecology, Obstetrics and Gynaecological Oncology, University Clinical Centre, Medical University of Silesia
    Katowice, Poland
    Recruiting
  • Oddział Ginekologii Onkologicznej z Pododdziałem Urologii, Opolskie Centrum Onkologii
    Opole, Poland
    Recruiting
  • Department of Gynaecological Oncology,
    Wroclaw, Poland
    Recruiting
  • Uniwersyteckie Centrum Onkologii, Uniwersytecki Szpital Kliniczny w Białymstoku
    Bialystok, Poland
    Not yet recruiting
  • Klinika Ginekologii, Świętokrzyskie Centrum Onkologii, Samodzielny Publiczny Zakład Opieki Zdrowotnej
    Kielce, Poland
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.